← Leaderboards
Hannah Marie Peterson
Boston University (Charles River Campus)
$1,784,506
Attributed
$1,784,506
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,784,506 · 4
By mechanism
R44$942,272 · 1
R43$404,994 · 1
R42$394,990 · 1
F31$42,250 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University (Charles River Campus)
Same institution · by research overlap
- Ji-Xin Cheng$30,661,505
- Aria Pearlman Morales$108,512
- Kavon Karrobi$100,134
- Aarohi Mahesh Mehendale$41,987
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorCellsMolecular AnalysisBiological MarkersResistanceNext GenerationProtein ExpressionPreservationSamplingSignal TransductionComplexTechnologyCancer PatientPathologyAdoptionBiopsy SpecimenBiomarker DevelopmentAntibodiesAccelerationCommercializationComputational AlgorithmChemistryBindingDiagnostic
Grant awards (6)
Rapid, Single Cell Proteomic Profiling for Biomarker Development in Precision Oncology$942,272
R44 · FY2025 · CA · contact PI
Cyclic Immunofluorescent Imaging in Live Cells$404,994
R43 · FY2025 · CA · contact PI
Rapid, Single Cell Proteomic Profiling for Biomarker Development in Precision Oncology$339,990
R42 · FY2024 · CA · contact PI
Rapid, Single Cell Proteomic Profiling for Biomarker Development in Precision Oncology$55,000
R42 · FY2024 · CA · contact PI
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging$4,168
F31 · FY2019 · CA · contact PI
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging$38,082
F31 · FY2018 · CA · contact PI